Virax Biolabs Group Limited (VRAX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Virax Biolabs Group Limit...

    NASDAQ: VRAX · Real-Time Price · USD
    0.56
    -0.05 (-7.70%)
    At close: Sep 05, 2025, 3:59 PM
    0.56
    -0.50%
    After-hours: Sep 05, 2025, 07:33 PM EDT

    Virax Biolabs Income Statement

    Financials in USD. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
    Revenue
    		 6.33K 156.42K 8.56K n/a 123.82K
    Cost of Revenue
    		 59.4K 105.83K 9.93K n/a 133.25K
    Gross Profit
    		 -53.07K 50.59K -1.36K n/a -9.43K
    Operating Income
    		 -6.16M -6.5M -5.73M -1.73M -644.54K
    Interest Income
    		 n/a n/a n/a 15.44K n/a
    Pretax Income
    		 -6.2M -6.74M -5.46M -1.75M -672.91K
    Net Income
    		 -6.06M -6.73M -5.46M -1.71M -650.98K
    Selling & General & Admin
    		 4.33M 4.59M 5.33M 1.3M 514.88K
    Research & Development
    		 1.78M 1.56M 397.11K 433.74K 120.22K
    Other Expenses
    		 n/a 390.36K n/a n/a 266.00
    Operating Expenses
    		 6.11M 6.55M 5.73M 1.73M 635.1K
    Interest Expense
    		 58.18K 26.88K 15.47K 15.44K 28.64K
    Selling & Marketing Expenses
    		 n/a n/a 26.62K 13.82K 57.2K
    Cost & Expenses
    		 6.17M 6.65M 5.74M 1.73M 768.36K
    Income Tax Expense
    		 -136.66K n/a -271 n/a n/a
    Shares Outstanding (Basic)
    		 3.1M 2.01M 1.06M 1.14M 1.14M
    Shares Outstanding (Diluted)
    		 3.1M 2.01M 1.06M 1.14M 1.14M
    EPS (Basic)
    		 -1.96 -3.36 -5.13 -1.5 -0.57
    EPS (Diluted)
    		 -1.95 -3.36 -5.13 -1.5 -0.57
    EBITDA
    		 -5.8M -6.61M -5.44M -750 n/a
    EBIT
    		 -6.15M -6.71M -5.44M -1.73M -644.27K
    Depreciation & Amortization
    		 343.39K 103.1K n/a 1.73M 644.54K

    Add to Watchlist